P1vital Head Office - Manor House, Howbery Park, Wallingford, Oxfordshire, OX10 8BA

P1vital’s Advisory panel is comprised of internationally renowned Psychopharmacologists and Neuroscientists with expertise in anxiety, depression, schizophrenia, cognition, obesity and addiction. (hover over names for more detail)

Professor Bill Deakin Department of Psychiatry, University of Manchester

Bill Deakin has been Professor of Psychiatry at the University of Manchester since 1990. His research interests are in developing new treatments for depression and schizophrenia based on imaging and other investigations of normal and pathological neurotransmitter function, particularly of the serotonin and glutamate systems in humans.

Professor Nick Girdler School of Dentistry, Newcastle University

Nick Girdler is Professor of Sedation Dentistry at Newcastle University. His research interests are in sedation dentistry and the treatment of anxiety disorders in patients with dental phobia.

Professor Guy Goodwin Department of Psychiatry, University of Oxford

Guy Goodwin has been W A Handley Professor of Psychiatry at the University of Oxford since 1996. His research interests are in the treatment of bipolar disorder and the application of neuroscience in understanding the neurobiology of mood disorder and developing new treatments.

Professor Catherine Harmer Department of Psychiatry, University of Oxford

Catherine Harmer is a Professor of Cognitive Neuroscience and Head of the Psychopharmacology and Emotion Research laboratory at the University Department of Psychiatry in Oxford. Her interests focus on the neuropsychology of antidepressant and anxiolytic drug action and in the development of early biomarker tests of drug efficacy.

Dr Suzanne Higgs School of Psychology, University of Birmingham

Suzanne Higgs is a Reader in the School of Psychology at the University of Birmingham. Her research interests focus on cognitive and biological influences on appetite, including the role of learning and memory in controlling food intake and drug taking, and the potential role of these factors in the development of obesity and drug addiction.

Professor Robin G Morris Clinical Neuropsychology, King's College Hospital, London

Robin G Morris is a consultant neuropsychologist at King’s College Hospital, where he is head of the Clinical Neuropsychology Department. His main interests are in the neuropsychology of memory and also of executive functioning. He has conducted research on a range of patients with neuropsychological disorder, including those with focal brain damage, schizophrenia, and Alzheimer’s disease.

Professor David Nutt Neuropsychopharmacology, Imperial College London

David Nutt is The Edmond J Safra Chair in Neuropsychopharmacology at Imperial College London. His research interests are in the psychopharmacology of anxiety, addiction and insomnia.

Professor John Wilding Department of Medicine, University of Liverpool

John Wilding is Head of the Department of Obesity and Endocrinology at the University of Liverpool. His research interests are in the clinical management of obesity and diabetes, the neurobiology of obesity and the development of new treatments for obesity and metabolic disorders.

Professor Lawrence Wilkinson Department of Medicine & School of Psychology, Cardiff University

Lawrence Wilkinson is Professor of Behavioural Genetics and Head of the Behavioural Genetics Group at Cardiff University. His research interests include the study of gene variants influencing impulsive behaviours, the familial dementias, imprinted gene effects on behaviour and the translation of pre-clinical models into a better understanding of psychopathology in people

Professor Steve Williams Department of Imaging Sciences, Institute of Psychiatry

Steve Williams is Professor of Imaging Sciences and Head of the Centre for Neuroimaging Sciences at the Institute of Psychiatry, King’s College London. His research interests include the development of novel imaging methods for visualising CNS disorders and the translation of imaging methods from pre-clinical observations to the clinic.